---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-153110"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2022-05-17T23:59:59+00:00"
generated_at: "2026-06-25T11:05:15.958596+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Inovio appoints CEO Shea to board; shareholders approve auditor and exec compensation vote

## Summary
- CEO Jacqueline Shea appointed to board following May 16, 2022 annual meeting; term until 2023 annual meeting.
- All seven director nominees elected; highest votes for David Weiner (53.2M), lowest for Lota Zoth (48.1M for).
- Ratification of Ernst & Young as auditor passed with 109.6M for, 6.7M against, 1.4M abstain.
- Advisory 'say-on-pay' vote passed with 40.8M for, 16.9M against, 0.7M abstain; broker non-votes 59.2M.

## SEC filing metadata
- accession: 0001193125-22-153110
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2022-05-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312522153110/0001193125-22-153110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312522153110/d338053d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-153110
- JSON: https://secwatch.observer/filing/0001193125-22-153110.json
- Plain text: https://secwatch.observer/filing/0001193125-22-153110.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.